almagate has been researched along with Chronic Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arevalo, JF; Espinoza, JV | 1 |
| Frenkel, MP; Frenkel, RE; Mani, L; Toler, AR | 1 |
| Feucht, N; Kotliar, KE; Lanzl, IM; Lohmann, CP; Maier, M | 1 |
3 other study(ies) available for almagate and Chronic Disease
| Article | Year |
|---|---|
Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Central Serous Chorioretinopathy; Chronic Disease; Combined Modality Therapy; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Intravitreal Injections; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Porphyrins; Retrospective Studies; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Verteporfin; Visual Acuity | 2011 |
Intraocular pressure effects of pegaptanib (Macugen) injections in patients with and without glaucoma.
Topics: Aged; Antihypertensive Agents; Aptamers, Nucleotide; Chronic Disease; Glaucoma, Open-Angle; Humans; Injections; Intraocular Pressure; Macular Degeneration; Retrospective Studies; Time Factors; Tonometry, Ocular; Vascular Endothelial Growth Factor A; Vitreous Body | 2007 |
Intraocular pressure effects of pegaptanib (macugen) injections in patients with and without glaucoma.
Topics: Angiogenesis Inhibitors; Aptamers, Nucleotide; Chronic Disease; Glaucoma, Open-Angle; Humans; Injections; Intraocular Pressure; Macular Degeneration; Tonometry, Ocular; Vascular Endothelial Growth Factor A; Vitreous Body | 2008 |